Current insights and future directions of LncRNA Morrbid in disease pathogenesis
- PMID: 39263145
- PMCID: PMC11388785
- DOI: 10.1016/j.heliyon.2024.e36681
Current insights and future directions of LncRNA Morrbid in disease pathogenesis
Abstract
Non-coding RNAs have emerged as important regulators of gene expression and contributors to many diseases. LncRNA Morrbid, a long non-coding RNA, has been widely studied in recent years. Current literature reports that lncRNA Morrbid is involved in various diseases such as tumors, cardiovascular diseases, inflammatory diseases and metabolic disorder. However, controversial conclusions exist in current studies. As a potential therapeutic target, it is necessary to comprehensively review the current evidence. In this work, we carefully review the literature on Morrbid and discuss each of the hot topics related to lncRNA Morrbid.
Keywords: Cardiovascular disease; LncRNA Morrbid; Long non-coding RNA; MIR4435-2HG; Tumor.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Chunxiang Zhang reports financial support was provided by 10.13039/501100001809National Natural Science Foundation of China, China. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Leukocyte-Specific Morrbid Promotes Leukocyte Differentiation and Atherogenesis.Research (Wash D C). 2023 Jul 6;6:0187. doi: 10.34133/research.0187. eCollection 2023. Research (Wash D C). 2023. PMID: 37426471 Free PMC article.
-
Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction.JCI Insight. 2023 Aug 22;8(16):e165568. doi: 10.1172/jci.insight.165568. JCI Insight. 2023. PMID: 37432746 Free PMC article.
-
Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders.Cancer Cell Int. 2022 Jun 17;22(1):215. doi: 10.1186/s12935-022-02633-8. Cancer Cell Int. 2022. PMID: 35715800 Free PMC article. Review.
-
LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1771-1777. doi: 10.26355/eurrev_202002_20354. Eur Rev Med Pharmacol Sci. 2020. PMID: 32141545
-
MIR4435-2HG: A newly proposed lncRNA in human cancer.Biomed Pharmacother. 2022 Jun;150:112971. doi: 10.1016/j.biopha.2022.112971. Epub 2022 Apr 18. Biomed Pharmacother. 2022. PMID: 35447550 Review.
References
-
- Marziyeh Bayat H.N., Mohammad Fazilati, Hossein Hejazi, Mohammd Ghaedi MaK. Association of MIR4435-2HG expression with TP53 mutation, estrogen receptor activity, and poor prognosis in breast cancer. Jentashapir J. Cell Mol. Biol. 2023;14(4)
-
- Zhao X.D., Liu Y.B., Yu S. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Biochim. Biophys. Acta, Mol. Basis Dis. 2017;1863(7):1805–1816. - PubMed
-
- Wang B., Tang D.Y., Zhang Z.Y., et al. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma. J. Cell. Biochem. 2020;121(2):1491–1503. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials